SCHEMBL7653247

SCHEMBL7653247

O=C(O)C1(c2ccccc2)CC2CC2C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 1/20 0.57
ALOX15 P16050 1/20 0.47
KMT2A Q03164 3/20 0.46
OPRM1 P35372 1/20 0.46
OPRL1 P41146 1/20 0.46
SIGMAR1 Q99720 1/20 0.43
HDAC4 P56524 3/20 0.43
TET3 O43151 1/20 0.42
FBXL19 Q6PCT2 1/20 0.42
CXXC5 Q7LFL8 1/20 0.42
TET1 Q8NFU7 1/20 0.42
KDM2B Q8NHM5 1/20 0.42
CXXC4 Q9H2H0 1/20 0.42
KDM2A Q9Y2K7 1/20 0.42
MAOB P27338 1/20 0.42
CYP2C19 P33261 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HSD11B1 P28845 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15215644 0.82 AKR1C1 (0.59) AKR1C1ALOX15KMT2AOPRM1OPRL1
SCHEMBL17222224 0.82 AKR1C1 (0.59) AKR1C1ALOX15KMT2AOPRM1OPRL1
SCHEMBL8112628 0.80 AKR1C1 (0.57) AKR1C1ALOX15KMT2AOPRM1OPRL1
SCHEMBL8106538 0.80 AKR1C1 (0.57) AKR1C1ALOX15KMT2AOPRM1OPRL1
SCHEMBL8110723 0.80 AKR1C1 (0.57) AKR1C1ALOX15KMT2AOPRM1OPRL1
SCHEMBL10550500 0.80 AKR1C1 (0.57) AKR1C1ALOX15KMT2AOPRM1OPRL1
Hydrochloric Acid SCHEMBL8106513 0.78 OPRL1 (0.51) AKR1C1ALOX15OPRM1OPRL1LMNA
SCHEMBL31016196 0.76 AKR1C1 (0.83) AKR1C1ALOX15KMT2AHDAC4TET3
SCHEMBL6391 0.76 AKR1C1 (0.83) AKR1C1ALOX15KMT2AHDAC4TET3
SCHEMBL3152584 0.76 AKR1C1 (0.52) AKR1C1ALOX15KMT2AOPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358956-B1 IMIDAZOLYLALKYL-1-PIPERAZINE DERIVATIVES; FARNESYL-PROTEIN AND GERANYLGERANYL TRANSFERASE INHIBITORS; ANTICARCINOGENIC AGENTS MERCK & CO., INC. 2002-03-19 US disclosed